Quick Takeaways
- Bios Equity Partners, LP filed SCHEDULE 13D/A for Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN).
- Disclosed ownership: 7.4%.
- Date of event: 16 Apr 2026.
Bios Equity Partners, LP - 16 Apr 2026 SCHEDULE 13D/A Report for Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN)
- Filing Manager
- Bios Equity Partners, LP
- Reporting Manager
- Fletcher Aaron G.L.
- Symbol
- LTRN
- Shares outstanding
- 11,280,432 shares
- Disclosed Ownership
- 834,752 shares
- Ownership
- 7.4%
- Form type
- SCHEDULE 13D/A
- Filing time
- 16 Apr 2026, 15:48:15 UTC
- Date of event
- 16 Apr 2026
- Previous filing
- 23 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Bios Equity Partners, LP disclosed 7.4% ownership in Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN) on 16 Apr 2026."
What Changed
- Previous schedule filing date: 23 Feb 2026.
- Current filing was accepted on 16 Apr 2026, 15:48.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (14)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bios Equity Partners, LP | 3.7% | 420,802 | 0 | 420,802 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813314 |
| Fletcher Aaron G.L. | 7.4% | 834,752 | 0 | 834,752 | /s/ John Fucci | John Fucci, as Attorney-in-Fact for Aaron G.L. Fletcher | 0001789490 |
| BIOS Advisors GP, LLC | 7.4% | 834,752 | 0 | 834,752 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813844 |
| BIOS Capital Management, LP | 7.4% | 834,752 | 0 | 834,752 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813845 |
| Bios Equity Partners II, LP | 3.7% | 413,950 | 0 | 413,950 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813313 |
| BIOS Fund II, LP | 0.8% | 88,029 | 0 | 88,029 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001714576 |
| BIOS Fund II NT, LP | 0.3% | 38,479 | 0 | 38,479 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001728851 |
| BIOS Fund II QP, LP | 2.6% | 287,442 | 0 | 287,442 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001716869 |
| BIOS Fund I, LP | 2.2% | 249,037 | 0 | 249,037 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001697316 |
| BIOS Fund I QP, LP | 1.3% | 145,672 | 0 | 145,672 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001700297 |
| BP Directors, LP | 0.2% | 26,093 | 0 | 26,093 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813311 |
| Cavu Advisors, LLC | 7.4% | 834,752 | 0 | 834,752 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813310 |
| Cavu Management, LP | 7.4% | 834,752 | 0 | 834,752 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813270 |
| Kreis Leslie W. | 7.4% | 834,752 | 0 | 834,752 | /s/ John Fucci | John Fucci, as Attorney-in-Fact for Leslie W. Kreis, Jr. | 0001813316 |